Truist Financial Lowers National Health Investors (NYSE:NHI) Price Target to $72.00

National Health Investors (NYSE:NHI) had its price target lowered by stock analysts at Truist Financial from $78.00 to $72.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price objective would suggest a potential upside of 3.78% from the stock’s current price.

A number of other research analysts also recently issued reports on the stock. StockNews.com downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and increased their target price for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Bank of America assumed coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $75.33.

National Health Investors Trading Up 0.5 %

Shares of NHI stock opened at $69.38 on Monday. National Health Investors has a twelve month low of $51.59 and a twelve month high of $86.13. The stock’s fifty day simple moving average is $75.72 and its 200 day simple moving average is $75.70. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The firm has a market capitalization of $3.15 billion, a P/E ratio of 23.84, a P/E/G ratio of 4.86 and a beta of 1.04.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. During the same period in the prior year, the company earned $1.08 EPS. The business’s quarterly revenue was up 1.7% compared to the same quarter last year. As a group, sell-side analysts predict that National Health Investors will post 4.42 EPS for the current fiscal year.

Institutional Investors Weigh In On National Health Investors

Hedge funds have recently modified their holdings of the stock. Quarry LP bought a new stake in shares of National Health Investors in the third quarter valued at $27,000. Covestor Ltd increased its stake in shares of National Health Investors by 2,700.0% in the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 405 shares in the last quarter. Point72 DIFC Ltd purchased a new position in National Health Investors in the 3rd quarter valued at approximately $35,000. Loomis Sayles & Co. L P bought a new stake in shares of National Health Investors during the 3rd quarter valued at $38,000. Finally, International Assets Investment Management LLC bought a new stake in shares of National Health Investors during the second quarter valued at about $36,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.